Thus, the combination of VMAT inhibitor with COMT/MAO inhibitor (MYCN-cluster) or MIBG radiation therapy (ATRX-cluster) might be a potential therapeutic strategy for treating neuroblastoma cases. The gene discussed is ATRX; the disease is neuroblastoma.